Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach

PURPOSE: Targeted therapies are effective therapeutic approaches in advanced stages of NSCLC and require precise molecular profiling to identify oncogenic drivers. Differential diagnosis on a molecular level contributes to clinical decision making. Liquid biopsy (LB) use has demonstrated its potenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Englmeier, Fabienne, Bleckmann, Annalen, Brückl, Wolfgang, Griesinger, Frank, Fleitz, Annette, Nagels, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020305/
https://www.ncbi.nlm.nih.gov/pubmed/35532791
http://dx.doi.org/10.1007/s00432-022-04034-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020305/
https://www.ncbi.nlm.nih.gov/pubmed/35532791
http://dx.doi.org/10.1007/s00432-022-04034-w

Ejemplares similares